Aidea started in development and production of human urinary protein, and now we have R&D platforms of protein and chemical drugs. Aidea has been devoted to research and development of innovative drugs in antitumor, antiviral and cardiovascular fields.
The R&D core team consists of famous pharmaceutical experts at home and abroad, among which there are 12 scientists with Ph.D.
Aidea has applied for 22 national patents by October, 2016. Among them, 5 invention patents and 9 utility model patents have been granted.